ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
16,895.20
-0.97%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.56
0.39%
Bitcoin
63,946.63
-0.52%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Repare Therapeutics Inc (RPTX) Quote

Repare Therapeutics Inc

Repare Therapeutics Inc (RPTX)

NASDAQ
3.30
-0.06
(-1.79%)
Closed April 24 4:00PM
Delayed by 15 minutes
3.30
0.00
( 0.00% )
Pre Market: 4:05AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.30
Bid
3.20
Ask
5.28
Volume
-
0.00 Day's Range 0.00
2.98 52 Week Range 13.85
Market Cap
139.201M
Previous Close
3.30
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
127,901
Shares Outstanding
42,182,177
Dividend Yield
-
PE Ratio
-1.48
Earnings Per Share (EPS)
-2.22
Revenue
51.13M
Net Profit
-93.8M

About Repare Therapeutics Inc

Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.reparerx.com
Headquarters
Saint-laurent, Quebec, Can
Founded
1970
Repare Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPTX. The last closing price for Repare Therapeutics was $3.30. Over the last year, Repare Therapeutics shares have traded in a share price range of $ 2.98 to $ 13.85.

Repare Therapeutics currently has 42,182,177 shares outstanding. The market capitalization of Repare Therapeutics is $139.20 million. Repare Therapeutics has a price to earnings ratio (PE ratio) of -1.48.

RPTX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 04 2024
Edgar (US Regulatory)

Repare Therapeutics to Participate in Two Upcoming Investor Conferences

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will...

February 29 2024
Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans

February 28 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

February 28 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 28 2024
Edgar (US Regulatory)

Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported financial results for the fourth quarter and full year...

February 28 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.113.448275862073.193.432.981434023.20811421CS
4-1.33-28.72570194384.634.882.981219943.80783031CS
12-3.25-49.61832061076.558.492.981279015.83987894CS
26-0.63-16.03053435113.938.492.982445655.45653892CS
52-6.33-65.73208722749.6313.852.981862786.78770906CS
156-28.78-89.713216957632.0835.752.9823007713.98359108CS
260-28.75-89.703588143532.0546.442.9820878316.41201689CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ILAGIntelligent Living Application Group Inc
$ 0.8099
(49.98%)
44.46k
AIREreAlpha Tech Corporation
$ 1.64
(41.38%)
385.4k
CDTXCidara Therapeutics Inc
$ 17.29
(40.68%)
479
NUWENewellis Inc
$ 0.304
(20.59%)
6.92k
SBFMSunshine Biopharma Inc
$ 1.12
(20.43%)
167.34k
FBLGraniteShares ETF Trust GraniteShares
$ 19.25
(-28.09%)
10.85k
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3095
(-27.23%)
41.3k
METAMeta Platforms Inc
$ 425.03
(-13.87%)
57.04k
WIMIWiMi Hologram Cloud Inc
$ 1.01
(-12.17%)
26.62k
BOFBranchOut Food Inc
$ 1.90
(-8.65%)
6.39k
AIREreAlpha Tech Corporation
$ 1.64
(41.38%)
385.4k
SBFMSunshine Biopharma Inc
$ 1.12
(20.43%)
167.34k
SQQQProShares UltraPro Short QQQ
$ 12.19
(3.22%)
166.07k
TQQQProShares UltraPro QQQ
$ 51.96
(-3.26%)
99.78k
FFIEFaraday Future Intelligent Electric Inc
$ 0.05
(0.20%)
68.81k

RPTX Discussion

View Posts
Monksdream Monksdream 8 months ago
From that awful Cathie Wood
Repare Therapeutics (RPTX)
icon-rise-1
17%
Shares of Repare Therapeutics traded up ~17% on Thursday after the company announced10 its second-quarter financial results. During its Research and Development Day in the fourth quarter, management will present updates on the company’s preclinical pipeline and disclose the target for RP-1664. Repare Therapeutics is a precision oncology company searching for novel therapeutics targets by using its discovery platform, SNIPRX.
👍️0
Gator44 Gator44 2 years ago
I believe we going to break 15 on today is close.
👍️0
ElusTrade ElusTrade 2 years ago
I believe we going hit 15 this week if not more....
👍️0
akamaii akamaii 2 years ago
Not alone bought on the news sold Friday 1290 flipped twice and long now again till 20 May flip along the way 15 next the deal is good stuff and the stock is down roche just put a seal of approval
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: We just busted-through to a "LUCKY THIRTEEN DOLLARS" price!!! NOT quite to the MOON, as they say. But what-the-FLICK, I'll take it!!

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Something is UP!!!! INDEED, a shinny-new GREEN COLOR for our --- well, at least MY shares --- of RPTX!! RPTX just might have some UPDATE NEWS coming next Monday, Peeps!! (HA-HA-HA!!!)

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: GREEN!!!! Green is beautiful!!! "GREEN-STOCKS-MATTER"!!!!!




"And by the way, iHub, I don't give a FLUCK if Morgan Fairchild just turned Sweet-116-Years old!!!!"
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Oooooops!!! You MM's can NOT keep our little GREEN-PRICE-Parrot away forever!!! So cut-that-out, you reprobate MM's!!!!

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: I just LOVE being ALONE over here!! (However, click handy LINK, below, for the "Bee Gees" EPIC ballad with THAT name!!! Maybe the BEST "ballad" ever done!!! Yet I'll wager that NOBODY here as ever even HEARD about this song!!! HA-HA-HA!!!)



👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Well, good morning, FOLKS!!! (Just trying to get a word in here edgewise is difficult, as you can see! We 'gots' so many POSTS here everyday, the iHub Algorithms simply can't handle the action!! )

In any event, GO-GO-GO-RPTX!!! Take us to the MOON today!! Well, at least maybe to the 'International SPACE STATION??? (HA-HA-HA!!!)

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: NOT a bad day here.
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Hey, 'RA-40' Dude, your post is the BEST point of the DAY about this RPTX-Roche-Company partnership!! Indeed, THAT many SHARES traded at the circa $9-$12 price range is impressive. This Company has nice, BIG, upside PRICE potential. Big-Time-ROCHE didn't cement that HUGE deal today because RPTX is some Stinky-Pinky-Wanna-Be-Big-PHARMA, with scores of USELESS "Patents-Pending"; nor weekly (Elementary School) Petri-Dish-&-Test-Tube-Studies; nor Miraculous-Sick-MICE-Cures!

See-ya tomorrow!!!

👍️0
retireat40 retireat40 2 years ago
No one noticing? Volume was 139 times normal
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: May have a late-day RUN here, Folks!! Whether anyone likes it, or not!!! (HA-HA-HA!!!)


"Heck, ya never know WHAT-THE-FLUCK is gonna happen on these Stock Market GAMBLING CASINOS these days!!!!"
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: They WILL notice this little GEM, Dude --- soon enough!!!

https://www.fool.com/investing/2022/06/02/why-repare-therapeutics-stock-is-skyrocketing-toda/
👍️0
ElusTrade ElusTrade 2 years ago
It huge news but no one noticing
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Now UP by a glorious 44%, Peeps & Homeboys!!! Don't miss the FUN -- let alone the PROFITS -- via this MONSTER Medical Science play!!! I guess nobody is YET paying any attention to today's NEWS about this little GEM!!! (HA-HA-HA!!!)

https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Ain't gonna be CRICKETS in here for very much longer, Folks!!!!

https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Yet another handy LINK (Fidelity) about this rather NICE news today for RPTX. (HA-HA-HA!!!)
https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=RPTX&pageno=&storyid=202206011618RTRSNEWSCOMBINED_FWN2XO0QP_1&provider=RTRSNEWS&product=COMBINED&
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Welcome aboard, Bro!!! This one is the proverbial, "Biggest No-Brainer In The History Of Mankind" routine!!! (Hey, I DO indeed realize that I am iHub's unoffical 'CLASS CLOWN'; but nevertheless, even FOOLS like me can pick-em ONCE in awhile!! HA-HA-HA!!!)


"Heck, I used to think that the ONLY time in my life that I ever got 'LUCKY', was winning a lousy Two-Dollar-Scratcher for TEN BUCKS in a 7/11-Store back in 1982! But with RPTX, I just hit the MOTHERLODE!!!! Bottom line, finally gettin' some RESPECT!!!!"
👍️0
Laszlo1 Laszlo1 2 years ago
I am in
👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Ya-all MISSED the take-off!! I am already well on my way to the MOON! Never been there, so it may be interesting!

"This is one small STEP for Mankind; but one GIANT LEAP for the bank account balance of iHub's own JUST-KEEP-TRYING Dude!!!" (HA-HA-HA!!!)

👍️0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Anybody gonna join me for a quick trip to the MOON today??? I can fly there all by MYSELF, but it sure gets LONELY way out there; but, I think I can MUSCLE-through-it, nevertheless. (HA-HA-HA!!)

https://www.marketwatch.com/story/roche-repares-licensing-deal-includes-milestone-payments-worth-up-to-12-billion-2022-06-02

https://pulse2.com/repare-therapeutics-rptx-stock-price-why-it-increased-over-20-today/

https://www.postregister.com/businessreport/healthcare/repare-therapeutics-announces-a-worldwide-license-and-collaboration-agreement-with-roche-for-camonsertib-rp-3500/article_a6d38b6f-626d-51f5-a151-9e0e435be816.html

https://www.marketbeat.com/instant-alerts/nasdaq-rptx-a-buy-or-sell-right-now-2022-06/


"Heck, last time I saw a stock like THIS rocketship, it landed on Planet JUPITER by lunchtime on Wall Street!"
👍️0

Your Recent History

NASDAQ
RPTX
Repare Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved